Citadel Advisors’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
RA
Citadel Advisors's BVS Position: Q2 2026 in Review
Citadel Advisors sold out of Bioventus (BVS) in Q2 2026, closing a stake of 17,085 shares — an estimated $163K sold.
Citadel Advisors first reported a position in BVS in Q2 2021 and held it in 18 quarters. The position peaked at $3.21M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.
- Citadel Advisors reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
- Citadel Advisors sold 17,085 Bioventus shares in Q2 2026, an estimated $163K.
- Citadel Advisors first reported a position in Bioventus in Q2 2021 and held it in 18 quarters.
- Citadel Advisors's Bioventus position peaked at $3.21M in Q3 2024.
- 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.